Upon completion of this activity, the participant should be able to:
Discuss issues surrounding PROP and what it means for Opioid prescribing in the future
Visit website: http://cme.dannemiller.com/videos/accreditation.cfm?id=464
Special New Year’s Discount now available!
$100 off online format, $200 off DVD/Audio/PowerStudyPak. Use discount code: NY2014.
This intensive review course is designed to examine current practices with emphasis on recent advances in the field of Physical Medicine and Rehabilitation.
Just a few reasons why the Health e Galaxy NYU Physical Medicine and Rehabilitation course is the premiere on-demand course:
Special New Year’s Discount now available!
$100 off online format, $200 off DVD/Audio/PowerStudyPak. Use discount code: NY2014
A convenient way to prepare for your Rheumatology Board Review, stay up to date with the latest approaches to patient care, and earn extensive CME credit.
Just a few reasons why the Health e Galaxy NYU Rheumatology Review Course is the premiere resource for on-demand board review preparation:
Rheumatologists, orthopedists, trainees in the rheumatic diseases and internists with a special interest in rheumatology
The annual Seminar in Advanced Rheumatology is an informative conference for rheumatologists, orthopedists, trainees in the rheumatic diseases and internists with a special interest in rheumatology. It will review and address those areas where recent, solid knowledge in the treatment of rheumatic diseases is available, focusing particularly on the state-of-the-art in rheumatology, at the leading edge between new clinical knowledge and its translation into practice. Rheumatology is a fast-moving field in which new discoveries are continually being made, and new treatment modalities developed. Because the basic and clinical scientific underpinnings of rheumatologic practice frequently and directly come to impact upon therapy, this course will also explore those areas of new science that are likely to prove important to the near-future management of patients with rheumatic disease.
Now in its eighth year, this symposium has been planned for the providers of care to patients with rheumatic diseases. Given the wide variety of rheumatologic disorders, and an ever-increasing number of diagnostic procedures and treatment options, it is necessary to provide clinicians with information about strategies for the early diagnosis of these conditions, novel state-of-the-art diagnostic tools, and opportunities to utilize the most effective treatments to ensure optimal patient outcomes. The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
Visit website: http://www.hopkinscme.edu/CourseDetail.aspx/80030960
The Advanced Critical Care Therapeutic course provides in-depth advanced instruction concerning the pharmacotherapeutic management of commonly encountered critical care diseases. Emphasis is placed on the efficacy, safety, and comparative value of drug therapy in this highly specialized practice area. Didactic knowledge of physiology, pharmacology, and drug therapy management is applied to disease states specific to this population. Didactic instruction is combined with practice case studies and interactive discussion concerning critical care realted issues. Partcipants may download material to view as a podcast on thier computer or handheld devices.
The program is delivered to participants using a distance education platform. Didactic lectures are electronically captured and packaged with written materials (references, case studies, self-evaluation quizzes) covering a total of 16 critical care topics.
Target Audience: The intended audience for the activity is rheumatologists, physical medicine and rehabilitation specialists, sports medicine physicians, and other healthcare professionals involved in the treatment of patients with osteoarthritis.
Learning Objectives: At the conclusion of this activity participants should be able to:
Explain the pharmacology of NSAIDs.
Compare and contrast the pharmacokinetics and pharmacodynamics of different NSAIDs.
Choose an appropriate NSAID for a specific patient based on drug properties and clinical picture of the patient.
Kimberleigh Stan, PharmD
Massachusetts General Hospital
Niyati Vakil, PharmD
Massachusetts General Hospital
Switching to a New Epilepsy Drug: Is New Always Better?
Myasthenic Antibodies and Disease Phenotype
A Trial of Intracranial Pressure Monitoring in Traumatic Brain Injury-What Do We Do Now?
MRI to Visualize Progression in Parkinson''s Disease
EEG and MRI Findings in Children with Febrile Status Epilepticus
Visit website: http://www.cmeweb.com/gcourse_view.php?course_id=11130
10 AMA PRA Category 1 Credits™
Audio CDs #AUDCD-1620131030
MP3 CD #MP3CD-1620131030
TOPIC LIST: The Neurological Examination • Libby Zion’s Lesson: Serotonin Syndrome and P450 Drug Interactions • Seizures and Epilepsy - Diagnosis • Seizures and Epilepsy - Management • Peripheral Neuropathy and Neuropathic Pain Management • Drugs, Alcohol and the Nervous System • Neurologic Emergencies
Restless legs syndrome (RLS) is a neurological disorder characterized by unpleasant sensations in the legs and a distressing, irresistible urge to move them. Prevalence estimates for RLS in the United States range from 1.5 to 7.4 percent in adults.
The clinical course of RLS varies. Periods of remission are common, particularly in younger patients and those with milder disease. Severe RLS, however, can be a chronic progressive disorder that may require long-term treatment. Recommended treatments for RLS include nonpharmacologic and pharmacologic strategies.
Clinicians face uncertainty related to defining RLS, assessing disease severity, and evaluating the risks and benefits of treatment. While these challenges apply to both primary care and specialty settings, they may be more pronounced in primary care. This systematic review aimed to address some of these challenges and uncertainties.
Visit website: http://www.baylorcme.org/trans/cme.cfm?activityID=352
Vertebral osteomyelitis (VO) and spinal epidural abscess (SEA) are rare infections or inflammations of the bone, bone marrow of the spinal region, or epidural space. Although rare (2.4 cases per 100,000 persons annually), they are relatively easy to treat when recognized. However, failure to recognize, diagnose and treat it in a timely manner can lead to permanent paralysis. Unfortunately, diagnostic delays occur frequently, with reports of symptom onset to diagnosis ranging from 11 to 59 days.
This CME activity addresses the diagnosis and initial treatment of vertebral osteomyelitis, discitis or paravertebral abscess with or without spinal epidural abscess in adult patients. The CME activity does not address antimicrobial adjustments once microorganisms have been identified, or indications for surgery.
CME Providers: List your actvities here.
Mar. 18, 2013 -- Osteopathic manual therapy was effective in alleviating chronic low back pain to a clinically significant degree, a randomized study showed.
Mar. 13, 2013 -- Follow-up MRIs obtained among patients treated for sciatica found no discernible benefit for the repeat imaging study, researchers found.
Feb. 19, 2013 -- When patients overdose on prescription opioid painkillers, other drugs given for mental health disorders, including benzodiazepines and antidepressants, are often involved, researchers found.
Feb. 19, 2013 -- Fibromyalgia should be considered a condition that exists across a continuum in a population, and is not a categorical disorder as it has often been considered, researchers concluded from a survey analysis in Germany.
Feb. 11, 2013 -- A noninvasive device that electrically stimulates the trigeminal nerve prevented migraines for patients whose episodes were not well controlled by medication alone, a trial showed.
Jan. 8, 2013 -- Vitamin D supplements had no impact on pain or progression of knee osteoarthritis, researchers reported.
Dec. 2, 2012 -- A single epidural steroid injection led to a significant decrease in hip bone mineral density (BMD) among postmenopausal women, an observational study found.
Nov. 19, 2012 -- Children's chronic pain is associated with that of their parents, researchers found.
Nov. 13, 2012 -- Patients with sciatica derived minimal benefit from epidural corticosteroids, raising questions about the value of the treatment for the condition, authors of a meta-analysis concluded.
Oct. 31, 2012 -- BOSTON -- A mouth rinse containing the tricyclic antidepressant doxepin appears to relieve mucositis pain among patients with head and neck cancers better than plain water, researchers reported here.
Oct. 8, 2012 -- Marijuana extract pills may ease painful muscle stiffness for some patients with multiple sclerosis, a randomized trial affirmed.
Oct. 6, 2012 -- Fibromyalgia needs more recognition and understanding from clinicians, Serge Perrot, MD, of Paris Descartes University in Paris, France, tells ALLMedPage Today staff writer Nancy Walsh in this exclusive video report.
Sep. 10, 2012 -- Acupuncture provides more relief from various types of chronic pain than does usual care and should be considered a valid therapeutic option, the authors of a meta-analysis concluded.
Aug. 9, 2012 -- Routine practice of qigong, a form of meditative movement, significantly improved pain in patients with fibromyalgia and lessened the impact of the disorder, a randomized trial showed.
Jul. 12, 2012 -- Patients with axial spondyloarthritis may benefit from treatment with adalimumab (Humira) even if they don't have radiographic changes to the sacroiliac joints, researchers reported.